Showing results (1291-1300 of 1,368) with videos related to

Sort By:
Pageof 137
Vaccines|June 21, 2020
Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored VaccinesCésar López-Camacho, Giuditta De Lorenzo, Jose Luis Slon-Campos, et al.
Journal of Drugs in Dermatology : JDD|December 5, 2023
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual MeetingKathryn Lee, Michael J Woodbury, Melissa Peri Zundell, et al.
Haematologica|October 5, 2019
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trialSara Bringhen, Mattia D'Agostino, Laura Paris, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2017
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre studyG Cabibbo, S Petta, V Calvaruso, et al.
Blood|January 27, 2011
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformationDavide Rossi, Valeria Spina, Clara Deambrogi, et al.
Blood|August 13, 2011
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomideAlessandra Larocca, Federica Cavallo, Sara Bringhen, et al.
Leukemia & Lymphoma|April 10, 2020
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myelomaKatja Weisel, Meletios Dimopoulos, Philippe Moreau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple MyelomaAntonio Palumbo, Francesca Gay, Federica Cavallo, et al.
Neurological Research|June 14, 2005
Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?Gelsomina De Stasio, Deepika Rajesh, Patrizia Casalbore, et al.
Frontiers in Cardiovascular Medicine|June 27, 2022
Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical TrialCarolina T Macedo, Ticiana F Larocca, Márcia Noya-Rabelo, et al.
Pageof 137